DHG Pharmaceutical JSC (HOSE:DHG)

Vietnam · Delayed Price · Currency is VND

83,800

-1,000 (-1.18%)

At close: Nov 3, 2026

Market Cap	10.96T -20.6%
Revenue (ttm)	5.33T +6.9%
Net Income	824.84B -7.4%
EPS	6,308.75 -7.6%
Shares Out	130.75M
PE Ratio	13.28
Forward PE	11.80
Dividend	5,000.00 (5.97%)
Ex-Dividend Date	Sep 14, 2026

Volume	13,119
Open	85,000
Previous Close	84,800
Day's Range	83,800 - 85,000
52-Week Range	83,800 - 109,000
Beta	0.25
Analysts	n/a
Price Target	n/a
Est. Earnings	Jan 20, 2027

About DHG Pharmaceutical JSC

DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, dermatology, and beauty care products. It also manufactures and trades in health food, dietary and consumer health supplements, and pharmaceuticals cosmetic products. It also exports its products. DHG Pharmaceutical... [Read more]

Industry Pharmaceutical Preparations

Founded 1974

Employees 2,812

Stock Exchange Ho Chi Minh Stock Exchange

Ticker Symbol DHG

Full Company Profile

Financial Performance

In 2025, DHG Pharmaceutical JSC's revenue was 5.27 trillion, an increase of 7.82% compared to the previous year's 4.88 trillion. Earnings were 824.78 billion, an increase of 9.45%.

Financial Statements